Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 29 Breast Neoplasms 28 Brain Neoplasms 21 Neoplasms 16 Glioma 10 Pancreatic Neoplasms 9 Head and Neck Neoplasms 8 Lymphoma 7 Uterine Cervical Neoplasms 6 Urinary Bladder Neoplasms 6 Rectal Neoplasms 6 Glioblastoma 6 Colonic Neoplasms 6 Carcinoma, Hepatocellular 6 Lymphoma, Non-Hodgkin 5 Lung Neoplasms 5 Astrocytoma 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Liver Neoplasms 4 Disease 4 Central Nervous System Neoplasms 4 Stomach Neoplasms 3 Spinal Cord Neoplasms 3 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Esophageal Neoplasms 3 Carcinoma in Situ 3 Retinoblastoma 2 Pathologic Complete Response 2

Interventions

Paclitaxel 328 Carboplatin 323 Bevacizumab 171 Gemcitabine 106 liposomal doxorubicin 104 pembrolizumab 101 Cyclophosphamide 96 Topotecan 94 olaparib 92 Cisplatin 92 niraparib 69 Docetaxel 57 Taxes 52 Doxorubicin 51 Drug Therapy 45 fludarabine 40 Filgrastim 39 Nivolumab 37 Magnetic Resonance Spectroscopy 34 Surveys and Questionnaires 33 Specimen Handling 33 Etoposide 32 Hyperthermic Intraperitoneal Chemotherapy 31 Blood Specimen Collection 29 Immunoglobulin G 27 Disulfides 27 Peripheral Blood Stem Cell Transplantation 26 Cytoreduction Surgical Procedures 25 Albumin-Bound Paclitaxel 25 durvalumab 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Neoplasms × Magnetic Resonance Imaging × Clear all

NCT03526809 2018-05-16

MISSION-ovary

Cambridge University Hospitals NHS Foundation Trust

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡